Literature DB >> 17878606

Actions and mode of actions of FGF19 subfamily members.

Seiji Fukumoto1.   

Abstract

Fibroblast growth factors (FGFs) are humoral factors with diverse biological functions. While most FGFs were shown to work as local factors regulating cell growth and differentiation, recent investigations indicated that FGF19 subfamily members, FGF15/19, FGF21 and FGF23 work as systemic factors. FGF15/19 produced by intestine inhibits bile acid synthesis and FGF21from liver is involved in carbohydrate and lipid metabolism. In addition, FGF23 was shown to be produced by bone and regulate phosphate and vitamin D metabolism. Furthermore, these FGFs require klotho or betaklotho for their actions in addition to canonical FGF receptors. It is possible that these FGFs together with their receptor systems might be targets for novel therapeutic measures in the future.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17878606     DOI: 10.1507/endocrj.kr07e-002

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  43 in total

1.  FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.

Authors:  Xinle Wu; Hongfei Ge; Bryan Lemon; Steven Vonderfecht; Jennifer Weiszmann; Randy Hecht; Jamila Gupte; Todd Hager; Zhulun Wang; Richard Lindberg; Yang Li
Journal:  J Biol Chem       Date:  2009-12-15       Impact factor: 5.157

Review 2.  Liver zonation: Novel aspects of its regulation and its impact on homeostasis.

Authors:  Rolf Gebhardt; Madlen Matz-Soja
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Decrease of FGF19 contributes to the increase of fasting glucose in human in an insulin-independent manner.

Authors:  J Zhang; H Li; N Bai; Y Xu; Q Song; L Zhang; G Wu; S Chen; X Hou; C Wang; L Wei; A Xu; Q Fang; W Jia
Journal:  J Endocrinol Invest       Date:  2019-03-09       Impact factor: 4.256

4.  Sulfated glycosaminoglycans are required for specific and sensitive fibroblast growth factor (FGF) 19 signaling via FGF receptor 4 and betaKlotho.

Authors:  Masao Nakamura; Yuriko Uehara; Masahiro Asada; Emi Honda; Naoko Nagai; Koji Kimata; Masashi Suzuki; Toru Imamura
Journal:  J Biol Chem       Date:  2011-06-08       Impact factor: 5.157

Review 5.  Regulation and function of the FGF23/klotho endocrine pathways.

Authors:  Aline Martin; Valentin David; L Darryl Quarles
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 37.312

Review 6.  Fibroblast growth factor 21: from pharmacology to physiology.

Authors:  Steven A Kliewer; David J Mangelsdorf
Journal:  Am J Clin Nutr       Date:  2009-11-11       Impact factor: 7.045

7.  Low body mass index and dyslipidemia in dialysis patients linked to elevated plasma fibroblast growth factor 23.

Authors:  John R Montford; Michel Chonchol; Alfred K Cheung; James S Kaufman; Tom Greene; William L Roberts; Gerard Smits; Jessica Kendrick
Journal:  Am J Nephrol       Date:  2013-02-20       Impact factor: 3.754

8.  Role of FGF19 induced FGFR4 activation in the regulation of glucose homeostasis.

Authors:  Xinle Wu; Yang Li
Journal:  Aging (Albany NY)       Date:  2009-12-09       Impact factor: 5.682

9.  Increased susceptibility to diet-induced gallstones in liver fatty acid binding protein knockout mice.

Authors:  Yan Xie; Elizabeth P Newberry; Susan M Kennedy; Jianyang Luo; Nicholas O Davidson
Journal:  J Lipid Res       Date:  2009-01-09       Impact factor: 5.922

10.  Temporal and spatial expression of FGF ligands and receptors during Xenopus development.

Authors:  Robert Lea; Nancy Papalopulu; Enrique Amaya; Karel Dorey
Journal:  Dev Dyn       Date:  2009-06       Impact factor: 3.780

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.